We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Vivera Pharmaceuticals Launches Two New COVID-19 Diagnostic Tests for Detection of SARS-CoV-2 Antigens

By HospiMedica International staff writers
Posted on 02 Oct 2020
Vivera Pharmaceuticals’ (Newport Beach, CA, USA) Advanced Diagnostics Division has launched two new diagnostic tests for the detection of SARS-CoV-2 antigens in those with active infections from nasal or saliva specimens.

Vivera's COVx-RDA Antigen Test Saliva Collection Kit and COVx-RDA Antigen Test Nasal Collection Kit for SARS-CoV-2 are designed for rapid detection in high volume environments requiring highly accurate test results. More...
Vivera's new antigen tests are relatively easy to use and with results in 10 minutes, remove barriers to diagnosing acute infection. Complimentary to these antigen test kits are the rRT-PCR and antibody tests also made available by the company. Vivera's RT-PCR test is also a molecular diagnostic test for COVID-19 while its serological antibody test can help identify antibodies in individuals, indicative of an active or prior infection.

Both the COVx-RDA Saliva Collection and COVx-RDA Nasal Collection test kits have undergone extensive validation testing and Emergency Use Authorization applications are being filed with the FDA. The tests will be available for use by CLIA-certified laboratories and medical professionals. Unlike current antigen tests on the market that have been heavily publicized but are not yet available for the larger market, Vivera's COVx-RDA test kits are ready for use by laboratories and medical facilities immediately.

"With the addition of these two antigen test kits to our COVID-19 testing portfolio, Vivera's testing solutions encompass all of the different ways in which protocols can be developed for getting Americans back to work and school," said Dr. Stephen McColgan, Vivera Pharmaceuticals' Chief Medical Officer. "Antibody tests are ideal for high volume screening where infection numbers are declining. PCR and Antigen testing are designed for high volume testing where there are suspected outbreaks or increasing infection numbers."

"Being able to offer a trifecta of essential testing solutions in the fight against COVID-19 has always been Vivera's goal," added Olivia Karpinski, Vivera Pharmaceuticals' Vice President of Sales. "Diagnostic testing for COVID-19 is more critical than ever and Vivera's antigen tests will enable effective and informed public health decisions by bringing Americans one step closer to real time identification of infection."

Related Links:
Vivera Pharmaceuticals


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical System
Stealth AXiS
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: Restrata Matrix and Solventum V.A.C. Therapy brings two advanced technologies together into one path to support active wound healing. (Photo courtesy of Solventum)

Combined Wound Healing Approach Pairs Synthetic Scaffold With Negative Pressure Therapy

Managing complex wounds requires both structural support for tissue repair and a controlled environment that protects the healing process. Frequent dressing changes can disrupt the wound bed and add complexity... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

AI Model Detects Hidden Disease Signals in Routine CT Scans

Computed tomography (CT) scans are often performed to answer a specific diagnostic question, which can leave other potentially important findings outside the immediate clinical focus. As a result, opportunities... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.